“janet-woodcock” Archives

in
Entry Author Date Location
Bio Execs Talk Patient Advocacy, Duchenne Approval at BioForward Panel 09/28/16 Wisconsin
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
Sarepta Preps For Sales As Insurers Unlikely To Deny Duchenne Drug 09/22/16 Boston
Sarepta Prices $300K Duchenne Drug As FDA Rift Emerges Over Approval 09/19/16 Boston
After New Data, FDA Bucks Advisory Panel, Approves Sarepta’s Duchenne Drug 09/19/16 Boston
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug 05/25/16 Boston
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day 07/17/12 San Francisco
The Cancer Drug Dark Ages Are Coming to an End 10/31/11 National
Alkermes Sees Chance to Reinvent Vivitrol For Fighting Drug Addiction, Not Just Alcoholism 02/18/11 Boston
Momenta Pharma Competitor Lodges Ethics Complaint Against FDA Boss, WSJ Reports 08/12/09 Boston
Page 1 of 1